Healthcare provider profile · identity verified

Fan Wu, MD

Family Practice · BLOOMINGTON, IN · NPI 1154811610

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	400	108
Amlodipine Besylate	Amlodipine Besylate	350	99
Levothyroxine Sodium	Levothyroxine Sodium	316	81
Lisinopril	Lisinopril	267	63
Losartan Potassium	Losartan Potassium	226	61
Gabapentin	Gabapentin	215	45
Rosuvastatin Calcium	Rosuvastatin Calcium	196	60
Omeprazole	Omeprazole	175	43
Metoprolol Succinate	Metoprolol Succinate	152	41
Albuterol Sulfate Hfa	Albuterol Sulfate	151	50
Metformin Hcl	Metformin Hcl	149	45
Simvastatin	Simvastatin	112	24
Trazodone Hcl	Trazodone Hcl	110	32
Metformin Hcl Er	Metformin Hcl	103	32
Escitalopram Oxalate	Escitalopram Oxalate	100	26
Carvedilol	Carvedilol	96	25
Hydrochlorothiazide	Hydrochlorothiazide	93	27
Pantoprazole Sodium	Pantoprazole Sodium	90	22
Fluticasone Propionate	Fluticasone Propionate	77	27
Furosemide	Furosemide	73	22
Ozempic	Semaglutide	67	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	65	16
Duloxetine Hcl	Duloxetine Hcl	63	15
Montelukast Sodium	Montelukast Sodium	63	18
Tramadol Hcl	Tramadol Hcl	63	suppressed
Clopidogrel	Clopidogrel Bisulfate	59	15
Zolpidem Tartrate	Zolpidem Tartrate	59	12
Sertraline Hcl	Sertraline Hcl	58	17
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	57	57
Donepezil Hcl	Donepezil Hcl	57	15
Shingrix	Varicella-Zoster Ge/As01b/Pf	57	44
Famotidine	Famotidine	55	16
Potassium Chloride	Potassium Chloride	55	13
Metoprolol Tartrate	Metoprolol Tartrate	53	15
Hydralazine Hcl	Hydralazine Hcl	51	18
Valsartan	Valsartan	50	suppressed
Pravastatin Sodium	Pravastatin Sodium	49	14
Hydroxyzine Hcl	Hydroxyzine Hcl	47	15
Spironolactone	Spironolactone	46	16
Venlafaxine Hcl Er	Venlafaxine Hcl	46	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	14
Synthroid	Levothyroxine Sodium	44	12
Jardiance	Empagliflozin	43	12
Tamsulosin Hcl	Tamsulosin Hcl	43	13
Alendronate Sodium	Alendronate Sodium	42	12
Atenolol	Atenolol	42	suppressed
Tizanidine Hcl	Tizanidine Hcl	42	13
Ropinirole Hcl	Ropinirole Hcl	40	13
Allopurinol	Allopurinol	38	11
Januvia	Sitagliptin Phosphate	38	suppressed
Alprazolam	Alprazolam	37	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	11
Trulicity	Dulaglutide	36	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	35	suppressed
Buspirone Hcl	Buspirone Hcl	32	suppressed
Glipizide Er	Glipizide	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Glimepiride	Glimepiride	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	12
Ezetimibe	Ezetimibe	27	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Mounjaro	Tirzepatide	26	suppressed
Ondansetron Odt	Ondansetron	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	23	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Azithromycin	Azithromycin	22	21
Glipizide	Glipizide	19	suppressed
Nystatin	Nystatin	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Premarin	Estrogens, Conjugated	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Amoxicillin	Amoxicillin	17	14
Chlorthalidone	Chlorthalidone	17	suppressed
Clotrimazole	Clotrimazole	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	15
Gemfibrozil	Gemfibrozil	17	suppressed
Meloxicam	Meloxicam	17	suppressed
Mupirocin	Mupirocin	17	14
Valacyclovir	Valacyclovir Hcl	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Linzess	Linaclotide	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	11
Acyclovir	Acyclovir	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Eliquis	Apixaban	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Nabumetone	Nabumetone	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error